Register entry
BSP Pharmaceuticals SpA
- Registered sites
- 1
- Drug products
- 39
- Live patents
- 0
- Countries
- 1
- Base
- Italy
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| BSP Pharmaceuticals SpA | Latina Scalo (LT)Italy | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3007255826 |
Catalogue
Marketed products
39Showing 39 of 39.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Bendamustine HCI Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Bendamustine HCI Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Bortezomib 3.5mg/vial | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Denileukin diftitox lyo 300 mcg/vial CIT | INJECTION | DRUG FOR FURTHER PROCESSING |
| Halaven | eribulin mesylate | INJECTION | NDA |
| - | Loncastuximab tesirine | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Mirikizumab Inj 300 mg/15 mL Vial Reform | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | Mirikizumab Inj 300 mg/15mL Vial | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | Multiple-Dose Tirzepatide Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Multiple-Dose Tirzepatide Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Multiple-Dose Tirzepatide Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Multiple-Dose Tirzepatide Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Multiple-Dose Tirzepatide Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Multiple-Dose Tirzepatide Injection | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Patritumab deruxtecan | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Pemetrexed disodium heptahydrate | POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Pemetrexed disodium heptahydrate | POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Pivekimab sunirine drug product (DP) | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Polatuzumab Vedotin lyophilized vials 140 mg | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Polatuzumab Vedotin lyophilized vials 30 mg | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | TAR-200 | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Telisotuzumab vedotin | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | Trastuzumab Emtansine drug product 100 mg | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Trastuzumab Emtansine drug product 160 mg | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | cedazuridine and decitabine | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | enfortumab vedotin-ejfv for injection | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | enfortumab vedotin-ejfv for injection | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | mirvetuximab soravtansine gynx | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | pembrolizumab and berahyaluronidase alfa | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | pembrolizumab and berahyaluronidase alfa | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | sacituzumab govitecan | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | telisotuzumab vedotin | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | vestronidase alfa-vjbk | INJECTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.